Home › Companies › ENANTA PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and ENANTA PHARMACEUTICALS INC.’s Form 8-K, filed 2024-03-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore ENANTA PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are ENANTA PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-03-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Yujiro S. Hata | 13,127,063 | -- | -- | 2,392,002 | 1,156,191 | Majority: yes |
| Elect Director: Kristine Peterson | 12,994,324 | -- | -- | 2,524,741 | 1,156,191 | Majority: yes |
| Elect Director: Terry C. Vance | 12,169,732 | -- | -- | 3,209,519 | 1,296,005 | Majority: yes |
| Proposal 2: To Approve an Amendment to Our 2019 Equity Incentive Plan. The stockholders approved the amendment to our 2019 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance under the plan by 975,000 shares. | 8,076,566 | 7,421,300 | 21,356 | -- | 1,156,034 | Majority: yes |
| Proposal 3: To Approve, on an Advisory Basis, the Compensation Paid to the Company's Named Executive Officers. The stockholders approved the advisory vote on executive compensation, referred to as a "say-on-pay" vote. | 12,306,697 | 3,196,342 | 16,183 | -- | 1,156,034 | Majority: yes |
| Proposal 4: To Ratify the Appointment of PricewaterhouseCoopers LLP as Enanta's Independent Registered Public Accounting Firm for the 2024 Fiscal Year. The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registe | 14,571,800 | 27,373 | 2,076,083 | -- | 0 | Majority: yes |
Source: ENANTA PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-03-12 — read the filing on EDGAR.
Each item below shows how the 141 asset managers that disclosed a ENANTA PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3: To Approve, on an Advisory Basis, the Compensation Paid to the Company's Named Executive Officers. The stockholders approved the advisory vote on executive compensation, referred to as a "say-on-pay" vote.”): 12,306,697 for, 3,196,342 against, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 58% for, 15% against (73% of the company cast a for/against vote).
The 140 asset managers below cast 74% of the shares they voted on this item FOR (9,215,487 for, 3,174,662 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 0 | 2,070,000 | 0 | 0 | Against |
| Vanguard | 1,822,799 | 0 | 0 | 0 | For |
| BlackRock | 1,680,262 | 0 | 0 | 0 | For |
| DE Shaw | 504,484 | 0 | 0 | 0 | For |
| Fidelity | 463,945 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 430,982 | 0 | 0 | 0 | For |
| Renaissance | 409,563 | 0 | 0 | 0 | For |
| Northern Trust | 397,441 | 38 | 0 | 0 | For |
| State Street | 386,142 | 157 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 385,146 | 0 | 0 | 0 | For |
| Charles Schwab | 294,662 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 289,233 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 275,964 | 0 | 0 | Against |
| Federated Hermes | 0 | 243,178 | 0 | 0 | Against |
| UBS | 0 | 214,897 | 0 | 0 | Against |
| Two Sigma | 206,126 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 192,027 | 0 | 0 | 0 | For |
| JPMorgan | 186,813 | 0 | 0 | 0 | For |
| Goldman Sachs | 141,592 | 0 | 0 | 0 | For |
| Dimensional | 0 | 139,297 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 125,375 | 5,785 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 115,937 | 0 | 0 | 0 | For |
| AQR | 115,774 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 78,367 | 0 | 0 | 0 | For |
Showing the 25 largest of 140 asset managers. See all 140 in the interactive database.
Combines 2 wordings of this item as funds reported it.
52.1% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2: To Approve an Amendment to Our 2019 Equity Incentive Plan. The stockholders approved the amendment to our 2019 Equity Incentive Plan to increase the number of shares of Common Stock reserved for issuance unde”): 8,076,566 for, 7,421,300 against, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 38% for, 35% against (73% of the company cast a for/against vote).
The 58 asset managers below cast 83% of the shares they voted on this item FOR (3,605,757 for, 724,911 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,775,145 | 28,600 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 408,677 | 34,394 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 121,292 | 0 | 0 | 0 | For |
| Dimensional | 0 | 89,686 | 0 | 0 | Against |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 9,753 | 70,960 | 0 | 0 | Against |
| JPMorgan | 0 | 80,144 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 68,513 | 0 | 0 | Against |
| Equitable | 31,409 | 27,930 | 0 | 0 | For |
| TIAA | 0 | 54,434 | 0 | 0 | Against |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 0 | 31,473 | 0 | 0 | Against |
| Lincoln Financial | 0 | 27,653 | 0 | 0 | Against |
| Bridge Builder Trust | 7,870 | 16,666 | 0 | 0 | Against |
| GuideStone | 0 | 22,417 | 0 | 0 | Against |
| Thrivent | 0 | 15,689 | 0 | 0 | Against |
| PACE SELECT ADVISORS TRUST | 0 | 15,412 | 0 | 0 | Against |
| ALPS ETF Trust | 0 | 14,601 | 0 | 0 | Against |
| Northern Trust | 0 | 14,191 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 10,381 | 3,463 | 0 | Against |
| State Street | 0 | 11,195 | 0 | 0 | Against |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Kristine Peterson”): 12,994,324 for, 2,524,741 withheld, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 61% for, 12% withheld (73% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (4,188,597 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 121,292 | 0 | Abstain |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 16,666 | 0 | Abstain |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| Brighthouse | 10,381 | 0 | 3,463 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 3 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Terry C. Vance”): 12,169,732 for, 3,209,519 withheld, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 58% for, 15% withheld (73% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (4,122,921 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 121,292 | 0 | Abstain |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 31,409 | 0 | 27,930 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 16,666 | 0 | Abstain |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| Brighthouse | 10,381 | 0 | 3,463 | 0 | For |
| State Street | 1,124 | 0 | 10,071 | 0 | Abstain |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Yujiro S. Hata”): 13,127,063 for, 2,392,002 withheld, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 62% for, 11% withheld (73% of the company cast a for/withheld vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (4,188,597 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 121,292 | 0 | Abstain |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 7,870 | 0 | 16,666 | 0 | Abstain |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| Brighthouse | 10,381 | 0 | 3,463 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
ENANTA PHARMACEUTICALS INC.’s own tally for this item (“Proposal 4: To Ratify the Appointment of PricewaterhouseCoopers LLP as Enanta's Independent Registered Public Accounting Firm for the 2024 Fiscal Year. The stockholders ratified the appointment of PricewaterhouseCoopers ”): 14,571,800 for, 27,373 against, per its Form 8-K filed 2024-03-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 21,155,983 outstanding shares: 69% for, 0.2% against (69% of the company cast a for/against vote).
The 57 asset managers below cast 100% of the shares they voted on this item FOR (4,330,668 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,803,745 | 0 | 0 | 0 | For |
| BlackRock | 871,169 | 0 | 0 | 0 | For |
| Fidelity | 443,071 | 0 | 0 | 0 | For |
| Charles Schwab | 147,331 | 0 | 0 | 0 | For |
| Federated Hermes | 121,292 | 0 | 0 | 0 | For |
| Dimensional | 89,686 | 0 | 0 | 0 | For |
| Goldman Sachs | 88,276 | 0 | 0 | 0 | For |
| Nationwide | 80,713 | 0 | 0 | 0 | For |
| JPMorgan | 80,144 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,513 | 0 | 0 | 0 | For |
| Equitable | 59,339 | 0 | 0 | 0 | For |
| TIAA | 54,434 | 0 | 0 | 0 | For |
| Prudential/PGIM | 52,200 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,581 | 0 | 0 | 0 | For |
| Voya | 31,473 | 0 | 0 | 0 | For |
| Lincoln Financial | 27,653 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 24,536 | 0 | 0 | 0 | For |
| GuideStone | 22,417 | 0 | 0 | 0 | For |
| Thrivent | 15,689 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 15,412 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 14,601 | 0 | 0 | 0 | For |
| Northern Trust | 14,191 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 13,900 | 0 | 0 | 0 | For |
| Brighthouse | 10,381 | 0 | 3,463 | 0 | For |
| State Street | 11,195 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. See all 57 in the interactive database.
Ranked by the number of ENANTA PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 21,155,983 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | FARALLON CAPITAL MANAGEMENT LLC | 9.78% |
| 2 | Vanguard | 8.62% |
| 3 | BlackRock | 7.94% |
| 4 | DE Shaw | 2.38% |
| 5 | Fidelity | 2.19% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.04% |
| 7 | Renaissance | 1.94% |
| 8 | Northern Trust | 1.88% |
| 9 | State Street | 1.83% |
| 10 | ACADIAN ASSET MANAGEMENT LLC | 1.82% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Armistice Capital, LLC | 9.93% | DEF14A |
| Vanguard Group | 9.16% | 13F |
| Farallon Capital Management, LLC | 8.86% | DEF14A |
| BlackRock | 8.66% | 13F |
| Jay R. Luly, Ph.D. | 7.10% | DEF14A |
| Northern Trust | 4.41% | 13F |
| Yat Sun Or, Ph.D. | 2.72% | DEF14A |
| D.E. Shaw | 2.70% | 13F |
| Renaissance Technologies | 2.49% | 13F |
| Geode Capital | 2.09% | 13F |
Percentages above are of 21,155,983 shares outstanding, as reported by ENANTA PHARMACEUTICALS INC. on its Form 10-Q dated 2024-01-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ENANTA PHARMACEUTICALS INC.’s 10-Q dated 2024-01-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At ENANTA PHARMACEUTICALS INC.'s shareholder meeting held 2024-03-06, in the 2023-2024 proxy season, 141 asset managers reported how they voted on 6 ballot items in their SEC Form N-PX filings, covering 1,188 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation paid to our named executive officers, as… — FOR was 79% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ENANTA PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-03-12.
ENANTA PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.